SCHEMBL19626652

SCHEMBL19626652

Cc1nc(-c2cccc(C(=O)N3CCCC3)c2)cs1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.74
NPC1 O15118 3/20 0.74
RAB9A P51151 3/20 0.74
PKM P14618 1/20 0.74
RHOA P61586 2/20 0.61
HPGD P15428 7/20 0.59
NPSR1 Q6W5P4 1/20 0.57
ADORA2A P29274 1/20 0.53
ADORA1 P30542 1/20 0.53
TSHR P16473 1/20 0.51
RECQL P46063 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPK1 P28482 2/20 0.51
KDM4A O75164 1/20 0.50
KDM4B O94953 1/20 0.50
KDM5C P41229 1/20 0.50
KDM5B Q9UGL1 1/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15219362 0.89 ALDH1A1 (0.59) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL19626657 0.89 HPGD (0.76) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL19625479 0.86 NPC1 (0.56) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL13952827 0.81 ALDH1A1 (0.50) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL14318291 0.80 ATP4A (0.67) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL601034 0.79 HTT (0.68) ALDH1A1NPC1RAB9AHPGDTSHR
SCHEMBL1807091 0.79 RHOA (0.60) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL1807329 0.79 RHOA (0.60) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL14318276 0.79 ATP4A (0.69) ALDH1A1NPC1RAB9APKMRHOA
SCHEMBL600251 0.79 RHOA (0.57) ALDH1A1NPC1RAB9APKMRHOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885NPC1 2489/4885RAB9A 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.